Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-β-d-arabinofuranosyluracil: Comparison with bromovinyldeoxyuridine and acyclovir

This publication has 38 references indexed in Scilit:

• Selective in vitro and in vivo activities of 5-(2-haloalkyl)pyrimidine nucleoside analogs, particularly 5-(2-chloroethyl)-2'-deoxyuridine, against herpes simplex virus
  Antimicrobial Agents and Chemotherapy, 1985
• Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs
  Pharmacology & Therapeutics, 1984
• Synthesis and antiviral properties of some 2'-deoxy-5-(fluoroalkenyl)uridines
  Journal of Medicinal Chemistry, 1982
• Activation by thymidine kinase and potent antiherpetic activity of 2′-nor-2′-deoxyguanosine (2′NDG)
  Biochemical and Biophysical Research Communications, 1982
• Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir
  Antiviral Research, 1982
• Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice
  Antimicrobial Agents and Chemotherapy, 1982
• Comparative efficacy of antiherpes drugs in different cell lines
  Antimicrobial Agents and Chemotherapy, 1982
• Effects of Oral Treatment with Acyclovir and Bromovinyldeoxyuridine on the Establishment and Maintenance of Latent Herpes Simplex Virus Infection in Mice
  Journal of General Virology, 1981
• Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.
  BMJ, 1980
• Effect of Treatment with 5-Ethyl-2′-Deoxyuridine on Herpes Simplex Virus Encephalitis in Normal and Immunosuppressed Mice
  Antimicrobial Agents and Chemotherapy, 1978